Volkswagen and Sonae are testing a smart glove that gives workers a bionic assist in picking up heavy objects. » Read More
By: Javier E. David
President Donald Trump lashed out at Arizona Sen. John McCain for refusing to vote on the GOP's latest attempt reform Obamacare. » Read More
By: Bertha Coombs
Health insurance and hospital stocks surged Friday after Sen. John McCain said he could not vote for the latest bill to repeal Obamacare. » Read More
By: John W. Schoen
The biggest pain from the latest GOP health-care proposal would be felt by mostly blue states that expanded Medicaid coverage. » Read More
San Francisco residents will vote next year on whether flavored tobacco products can be sold in the city.
Antidote.me was founded by European tech veterans to help drug companies more effectively recruit patients for clinical trials.
This brave new world of robot caregivers won’t take shape unless they're user-friendly and intuitive, says Cynthia Matuszek.
While Shkreli awaits sentencing for a fraud conviction, he has been busy making mischief on social media platforms.
A new CDC report finds that progress in preventing strokes has stalled across the US for reasons that are still not well understood.
A number of senators want to guarantee key payments to insurers that compensate them for discounts given to many Obamacare customers.
Sarepta's Doug Ingram responds to a question about the high cost for a drug for Duchenne muscular dystrophy.
Statins are cheaper than ever, but new drugs, called PCSK9 inhibitors, are putting heart disease at center of battle over drug prices.
Verily, formerly Google life sciences, has opened a "partner space" for early-stage biotech businesses.
Sarepta Therapeutics reports positive results from a clinical trial of an experimental medicine for Duchenne muscular dystrophy.
Many Obamacare customers who use specialty drugs were hit with monthly costs of anywhere from $262 to $1,762 higher.
More than 60 percent of voters disapprove of how President Donald Trump is handling the issue of health care, a new poll finds.
Globalization has been key to Takeda Pharmaceutical's strategy to achieving growth, its CEO said.
ChemoWave helps patients track a wide variety of medical data like symptoms, exercise, water intake and medications.
Novartis Chief Executive Joseph Jimenez will retire in 2018, with chief drug developer Vasant Narasimhan taking over as CEO starting in February, the Swiss drugmaker said on Monday.
Health regulators in St. Kitts and Nevis are probing the 2016 clinical trial, which they said was conducted without prior official approval.
"Every major company ... in America has people in recovery," acting White House drug czar Richard Baum told CNBC.
Sutter Health thinks it has a way to use "predictive analytics" to cut costs. Here's how the California hospital group plans to do it.
Shares in Indivior plunged 40 percent Friday after it said a court ruling could lead to a generic rival to its treatment for opioid addiction.
Jim Cramer compiles a stock market dream team of technology, media and health care stocks.
Get the best of CNBC in your inbox